Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa Genuardi

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Frontiers in Immunology|August 23, 2024
In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T lymphocytes and enhances their effector response to tumor-associated antigensSilvia Brugiapaglia, Sara Bulfamante, Claudia Curcio, et al.
Annals of Hematology|January 4, 2021
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myelomaStefania Oliva, Lorenzo De Paoli, Marina Ruggeri, et al.
Hematological Oncology|November 21, 2013
Comparison of two real-time quantitative polymerase chain reaction strategies for minimal residual disease evaluation in lymphoproliferative disorders: correlation between immunoglobulin gene mutation load and real-time quantitative polymerase chain reaction performanceIrene Della Starza, Marzia Cavalli, Ilaria Del Giudice, et al.
Blood Cancer Journal|July 19, 2024
Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myelomaBachisio Ziccheddu, Claudia Giannotta, Mattia D'Agostino, et al.
Leukemia & Lymphoma|August 14, 2014
Comparison of different DNA extraction methods from peripheral blood cells: advice from the Fondazione Italiana Linfomi Minimal Residual Disease NetworkClaudia Mannu, Anna Gazzola, Elena Ciabatti, et al.
Medrxiv : the Preprint Server for Health Sciences|December 18, 2023
Genomic and immune determinants of resistance to anti-CD38 monoclonal antibody-based therapy in relapsed refractory multiple myelomaBachisio Ziccheddu, Claudia Giannotta, Mattia D'Agostino, et al.
Frontiers in Oncology|February 27, 2023
Differences in the immunoglobulin gene repertoires of IgG versus IgA multiple myeloma allude to distinct immunopathogenetic trajectoriesGlykeria Gkoliou, Andreas Agathangelidis, Georgos Karakatsoulis, et al.
Annals of Hematology|June 6, 2013
Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphomaSimone Ferrero, Luigia Monitillo, Barbara Mantoan, et al.
International Journal of Molecular Sciences|December 23, 2022
Single-Cell RNA Sequencing for the Detection of Clonotypic V(D)J Rearrangements in Multiple MyelomaAntonio Matera, Alessio Marella, Akihiro Maeda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2020
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation SequencingMattia D'Agostino, Gian Maria Zaccaria, Bachisio Ziccheddu, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Frontiers in Immunology|August 23, 2024
In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T lymphocytes and enhances their effector response to tumor-associated antigensSilvia Brugiapaglia, Sara Bulfamante, Claudia Curcio, et al.
Annals of Hematology|January 4, 2021
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myelomaStefania Oliva, Lorenzo De Paoli, Marina Ruggeri, et al.
Hematological Oncology|November 21, 2013
Comparison of two real-time quantitative polymerase chain reaction strategies for minimal residual disease evaluation in lymphoproliferative disorders: correlation between immunoglobulin gene mutation load and real-time quantitative polymerase chain reaction performanceIrene Della Starza, Marzia Cavalli, Ilaria Del Giudice, et al.
Blood Cancer Journal|July 19, 2024
Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myelomaBachisio Ziccheddu, Claudia Giannotta, Mattia D'Agostino, et al.
Leukemia & Lymphoma|August 14, 2014
Comparison of different DNA extraction methods from peripheral blood cells: advice from the Fondazione Italiana Linfomi Minimal Residual Disease NetworkClaudia Mannu, Anna Gazzola, Elena Ciabatti, et al.
Medrxiv : the Preprint Server for Health Sciences|December 18, 2023
Genomic and immune determinants of resistance to anti-CD38 monoclonal antibody-based therapy in relapsed refractory multiple myelomaBachisio Ziccheddu, Claudia Giannotta, Mattia D'Agostino, et al.
Frontiers in Oncology|February 27, 2023
Differences in the immunoglobulin gene repertoires of IgG versus IgA multiple myeloma allude to distinct immunopathogenetic trajectoriesGlykeria Gkoliou, Andreas Agathangelidis, Georgos Karakatsoulis, et al.
Annals of Hematology|June 6, 2013
Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphomaSimone Ferrero, Luigia Monitillo, Barbara Mantoan, et al.
International Journal of Molecular Sciences|December 23, 2022
Single-Cell RNA Sequencing for the Detection of Clonotypic V(D)J Rearrangements in Multiple MyelomaAntonio Matera, Alessio Marella, Akihiro Maeda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2020
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation SequencingMattia D'Agostino, Gian Maria Zaccaria, Bachisio Ziccheddu, et al.
Pageof 5